Response to direct acting antivirals in vertically HIV/HCV co-infected youths

被引：0

作者：

Carrasco, I. ^{[1
]}

Sainz, T. ^{[2
]}

Frick, M. A. ^{[3
]}

Jimenez de Ory, S. ^{[1
]}

Montero, M. ^{[4
]}

Gavilan, C. ^{[5
]}

Falcon, M. D. ^{[6
]}

Couceiro, J. A. ^{[7
]}

Bernardino, J. I. ^{[2
]}

Rubio, R. ^{[8
]}

Bisbal, O. ^{[8
]}

Guerrero, C. ^{[9
]}

Aldamiz-Echevarria, M. T. ^{[1
]}

Miralles, P. ^{[1
]}

Berenguer, J. ^{[1
]}

Navarro, M. L. ^{[1
]}

机构：

[1] IiSGM Gregorio Maranon Univ Hosp, Madrid, Spain

[2] La Paz Univ Hosp, Madrid, Spain

[3] Vall dHebron Univ Hosp, Barcelona, Spain

[4] La Fe Univ & Polytech Hosp, Valencia, Spain

[5] San Juan de Alicante Hosp, Alicante, Spain

[6] Virgen del Rocio Univ Hosp, Seville, Spain

[7] Pontevedra Hosp Complex, Pontevedra, Spain

[8] 12 Octubre Hosp, Madrid, Spain

[9] Miguel Servet Univ Hosp, Madrid, Spain

来源：

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2019年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

WEAB0205

引用

页码：48 / 48

页数：1

共 50 条

[1] Response to direct-acting antivirals for hepatitis C treatment in vertically HIV/HCV co-infected patients
Carrasco, Itziar
Sainz, Talia
Antoinette Frick, Marie
Jimenez de Ory, Santiago
Fortuny, Claudia
Burgos, Joaquin
Montero, Marta
Gavilan, Cesar
Dolores Falcon, Maria
Antonio Couceiro, Jose
Ignacio Bernardino, Jose
Bisbal, Otilia
Guerrero, Carmelo
Teresa Aldamiz-Echevarria, Maria
Berenguer, Juan
Luisa Navarro, Maria
JOURNAL OF VIRAL HEPATITIS, 2020, 27 (09) : 955 - 958
[2] Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals
Rockstroh, Juergen K.
LIVER INTERNATIONAL, 2015, 35 : 51 - 55
[3] Direct-acting Antivirals for HIV/HCV Co-infected Individuals: As Good as it Gets?
Bruno, Giuseppe
Saracino, Annalisa
CURRENT HIV RESEARCH, 2017, 15 (06) : 422 - 433
[4] Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)
L. Dold
C. Schwarze-Zander
C. Boesecke
R. Mohr
B. Langhans
J.-C. Wasmuth
C. P. Strassburg
J. K. Rockstroh
U. Spengler
Scientific Reports, 9
[5] Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)
Dold, L.
Schwarze-Zander, C.
Boesecke, C.
Mohr, R.
Langhans, B.
Wasmuth, J-C
Strassburg, C. P.
Rockstroh, J. K.
Spengler, U.
SCIENTIFIC REPORTS, 2019, 9 (1)
[6] Occurrence of hepatocellular carcinoma in HIV/HCV co-infected patients treated with direct-acting antivirals
Hasson, Hamid
Merli, Marco
Messina, Emanuela
Bhoori, Sherrie
Salpietro, Stefania
Morsica, Giulia
Regalia, Enrico
Bagaglio, Sabrina
Lazzarin, Adriano
Uberti-Foppa, Caterina
Mazzaferro, Vincenzo
JOURNAL OF HEPATOLOGY, 2017, 67 (02) : 415 - 417
[7] Lipid Profiles After Therapy with Direct-Acting Antivirals in HCV Mono-infected and HCV/HIV Co-infected Patients
Simmons, Okeefe L.
Drechsler, Henning
Kouma, Marcus
Brown, Geri
Bedimo, Roger
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S343 - S343
[8] Liver fibrosis regression in HIV-HCV co-infected individuals after sustained virologic response with HCV direct-acting antivirals
Arias, Ana
Lledo, Gemma
Trevino, Ana
Benitez-Gutierrez, Laura
Carrasco, Itziar
Cuervas-Mons, Valentin
De Mendoza, Carmen
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
[9] Impact of treatment with direct-acting antivirals on inflammatory markers and autoantibodies in HIV/HCV co-infected individuals
Rossotti, Roberto
Merli, Marco
Baiguera, Chiara
Bana, Nicholas Brian
Rezzonico, Leonardo Francesco
D'Amico, Federico
Raimondi, Alessandro
Moioli, Maria Cristina
Chianura, Leonardo Gerolamo
Puoti, Massimo
JOURNAL OF VIRAL HEPATITIS, 2023, 30 (06) : 530 - 539
[10] HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ?
Bruno, Giuseppe
Saracino, Annalisa
Scudeller, Luigia
Fabrizio, Claudia
Dell'Acqua, Raffaele
Milano, Eugenio
Milella, Michele
Ladisa, Nicoletta
Monno, Laura
Angarano, Gioacchino
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 62 : 64 - 71

← 1 2 3 4 5 →